Slater Technology Fund to invest in Alcinous Pharmaceuticals

PROVIDENCE – The Slater Technology Fund, along with private angel investors, will invest up to $600,000 in Alcinous Pharmaceuticals, the nonprofit seed fund announced on Tuesday. Alcinous was started by University of Rhode Island graduate students at the school’s College of Pharmacy by Nicholas DaSilva, Kenneth Rose and Benjamin Barlock, in 2017. The company is…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.